These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30914681)

  • 1. Nanoscale structure of amyloid-β plaques in Alzheimer's disease.
    Querol-Vilaseca M; Colom-Cadena M; Pegueroles J; Nuñez-Llaves R; Luque-Cabecerans J; Muñoz-Llahuna L; Andilla J; Belbin O; Spires-Jones TL; Gelpi E; Clarimon J; Loza-Alvarez P; Fortea J; Lleó A
    Sci Rep; 2019 Mar; 9(1):5181. PubMed ID: 30914681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
    Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
    Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease.
    Rasmussen J; Mahler J; Beschorner N; Kaeser SA; Häsler LM; Baumann F; Nyström S; Portelius E; Blennow K; Lashley T; Fox NC; Sepulveda-Falla D; Glatzel M; Oblak AL; Ghetti B; Nilsson KPR; Hammarström P; Staufenbiel M; Walker LC; Jucker M
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13018-13023. PubMed ID: 29158413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid.
    Nabuurs RJ; Natté R; de Ronde FM; Hegeman-Kleinn I; Dijkstra J; van Duinen SG; Webb AG; Rozemuller AJ; van Buchem MA; van der Weerd L
    J Alzheimers Dis; 2013; 34(4):1037-49. PubMed ID: 23340037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients.
    Ghosh U; Yau WM; Collinge J; Tycko R
    Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34725161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Nanomechanical Characterization of the HIV Tat-Amyloid β Peptide Multifibrillar Structures.
    Feng Q; Hong Y; Pradeep Nidamanuri N; Yang C; Li Q; Dong M
    Chemistry; 2020 Aug; 26(43):9449-9453. PubMed ID: 32167218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.
    Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC
    J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.
    Koffie RM; Meyer-Luehmann M; Hashimoto T; Adams KW; Mielke ML; Garcia-Alloza M; Micheva KD; Smith SJ; Kim ML; Lee VM; Hyman BT; Spires-Jones TL
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):4012-7. PubMed ID: 19228947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper Redox Cycling Inhibits Aβ Fibre Formation and Promotes Fibre Fragmentation, while Generating a Dityrosine Aβ Dimer.
    Gu M; Bode DC; Viles JH
    Sci Rep; 2018 Nov; 8(1):16190. PubMed ID: 30385800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
    Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
    FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A self-destructive nanosweeper that captures and clears amyloid β-peptides.
    Luo Q; Lin YX; Yang PP; Wang Y; Qi GB; Qiao ZY; Li BN; Zhang K; Zhang JP; Wang L; Wang H
    Nat Commun; 2018 May; 9(1):1802. PubMed ID: 29728565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.